跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
autophagy enhancer
首页
药物
autophagy enhancer
autophagy enhancer
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
MEDICINAL COMPOSITION FOR TREATING INFARCTION
US 2015064237 A1
申请人: UNIV GIFU
优先权: 2012
CN
EP
US
3 件公开
ANTICANCER AGENT KIT
EP 4806443 A1
申请人: NIHON TRIM CO LTD
优先权: 2023
EP
WO
2 件公开
Autophagy enhancer for treatment of neurodegenerative diseases
US 9005677 B2
申请人: UNIV MACAU SCI & TECH
优先权: 2014
US
2 件公开
N-desmethyldauricine, A Novel Autophagic Enhancer for Treatment of Cancers and Neurodegenerative Conditions Thereof
US 2015133492 A1
申请人: UNIV MACAU SCI & TECH
优先权: 2014
US
Autophagy enhancer and use thereof
US 10881642 B2
申请人: UNIV YONSEI IACF
优先权: 2016
US
Drug use of rocaglamide
CN 108066336 A
申请人: UNIV SHANGHAI TRADITIONAL CHINESE MEDICINE
优先权: 2016
CN
Application of EZH2 (Enhancer of Zeste Homolog 2) inhibitor in medicine for preventing or treating cardiovascular diseases caused by vascular smooth muscle cell proliferation
CN 108309978 A
申请人: AFFILIATED TONGJI HOSPITAL OF TONGJI MEDICAL COLLEGE OF HUAZHONG UNIV SCI & TECH
优先权: 2017
CN
Medicine for treating bone metabolic diseases and application thereof
CN 113599500 A
申请人: ZHUXIANYI MEMORIAL HOSPITAL OF TIANJIN MEDICAL UNIV TIANJIN MEDICAL UNIV METABOLIC DISEASE HOSPITAL
优先权: 2021
CN
Application of TAX1BP1 function enhancer in preparation of medicine for preventing or treating acute kidney injury
CN 120501843 A
申请人: FULING HOSPITAL CHONGQING UNIV
优先权: 2025
CN
Multi-target compound preparation for targeted neuron autophagy repair as well as preparation method and application of multi-target compound preparation
CN 121422231 A
申请人: SHAOXING 7TH PEOPLES HOSPITAL
优先权: 2025
CN
第 1 / 2 页
上一页
下一页
药物
反馈